EXPO
Neutral signalScored 2026-07-29 Drivers: Congress, fundamentals. Insiders: neutral. Moteurs : Congrès, fondamentaux. Initiés : neutre.
Research, not advice.
À propos
Exponent, Inc.
- Nom
- Exponent, Inc.
- Secteur
- Industrials
- Industrie
- Engineering & Construction
- Bourse
- NASDAQ
- Capitalisation
- $3.7B
- Employés
- 1,012
- PDG
- Catherine Ford Corrigan
- Site web
- https://www.exponent.com
- Marché
- CRAIFCNFLRHURNICFIKBR
Exponent, Inc. functions as a global leader in scientific and engineering consulting, operating through its subsidiaries. The firm's activities are divided into two principal segments: Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific division offers a broad spectrum of services encompassing biomechanics, biomedical sciences, structural analysis, civil engineering, construction advisory, data analytics, electrical and computer science, human factors, materials and corrosion science, mechanical engineering, polymer chemistry, thermal dynamics, and vehicle system engineering. Concurrently, the Environmental and Health segment specializes in areas such as chemical regulatory compliance, food safety, ecological and biological studies, earth and environmental sciences, and various health-related scientific fields. With expertise spanning approximately 90 technical disciplines, Exponent is dedicated to addressing complex and pressing issues for its stakeholders. Its client base is diverse, covering industries like chemicals, construction, consumer products, energy, food and beverage, government, life sciences, insurance, manufacturing, technology, heavy industrial equipment, and transportation. The company, originally established in 1967 as The Failure Group, Inc., rebranded as Exponent, Inc. in 1998, and its headquarters are located in Menlo Park, California.
Price (1 year)
Live chart from TradingView — independent market data, as price context around the filings, not the Quorum score. EMA 50/200 and Bollinger load by default. When the exchange is known it is sent as EXCHANGE:SYMBOL; otherwise TradingView resolves the ticker best-effort.
VENTE TOTALE: 3 444 titres (~222 180,55 $ US)
- Insiders
- Corrigan Catherine
- Total bought
-
—
Avg buy (VWAP, 90d window) $68.45 vs last close —
- Total sold
-
$113,136
Avg sell (VWAP, 90d window) $66.28 vs last close —
Total sold sums Form 4 code S in this window. Codes F, M, A and G are left out.
$113,136 of that total is under a Rule 10b5-1 plan. It is shown here and left out of the score.
- Last activity
- 2026-08-17
- Last synced
-
2026-08-23 00:12:53
Sign in to request a sync of this company's price history and timing levels.
Insider holdings as a share of total assets aren't available for this company.
Avg buy and avg sell are volume-weighted prices (sum of shares × price, divided by shares) for Form 4 rows in this 90-day window that report both figures. A comparison with last close is market context for that average, not advice.
Recent Form 4
Filings in the 90-day window for this company. Value is shares × price from the filing. Research, not advice.
| Date | Person | Side | Shares | Price | Value | Form 4 |
|---|---|---|---|---|---|---|
| 2026-09-18 | Souri Shukri Jeries | Buy · P | 184 | $68.45 | $12,594 | Form 4 |
| 2026-08-17 | Corrigan Catherine | Sell · S · 10b5-1 | 1,707 | $66.28 | $113,136 | Form 4 |
Sales marked 10b5-1 are scheduled in advance and don't count toward the Quorum score. Les ventes marquées 10b5-1 sont planifiées à l'avance et ne pèsent pas dans le score Quorum.
Congressional trades
STOCK Act disclosures (90-day window)
Amounts are STOCK Act brackets as disclosed. Quorum does not turn a bracket into an exact price or a midpoint.
No STOCK Act disclosures for this company in this window.
Recent trades
| Date | Representative | Type | Amount |
|---|---|---|---|
| 2025-09-11 | Lisa McClain | Sale (Full) | $1,001 - $15,000 |
| 2025-08-13 | Lisa McClain | Purchase | $1,001 - $15,000 |
| 2025-03-13 | Jefferson Shreve | Purchase | $15,001 - $50,000 |
| 2025-02-24 | Jefferson Shreve | Purchase | $15,001 - $50,000 |
Signal
Neutral signalScored 2026-07-29 Drivers: Congress, fundamentals. Insiders: neutral. Moteurs : Congrès, fondamentaux. Initiés : neutre.
EXPO's strong liquidity (score: 85) and debt-free balance sheet provide a solid structural foundation, but the declining fundamental trend (score: 45) — driven by margin compression and deteriorating ROA/ROIC —…
The first sentence of the analysis written for EXPO on 2026-07-29 - a real excerpt, not a sample. The rest of it, the 0-100 score and the rating it produced are part of Plus. See plans.
Factor checklist — research, not advice
A check leans with a bullish reading. A cross leans against it. A dash is unavailable or mixed.
- Insider Unavailable or mixed. – Insider: neutral. All sales (≈ $113K) were pre-planned Rule 10b5-1 trades, excluded from the score. No open-market buys or discretionary sales. – Initiés : neutre. Toutes les ventes (≈ $113K) sont sous plan 10b5-1 préétabli, exclues du score. Aucun achat ni vente discrétionnaire.
- Congress Supports a bullish reading. 3 purchase disclosures year to date
- Narrative Unavailable or mixed. Stored narrative reading is in the neutral band
- Timing Unavailable or mixed. No stored price series
- Financial indicators Supports a bullish reading. Current ratio 2.40 · operating margin 21%
Market snapshot
Financial ratios
| Metric | Trend | 2026-01-02 | 2025-01-03 | 2023-12-29 | 2022-12-30 | 2021-12-31 |
|---|---|---|---|---|---|---|
| Gross Profit Margin | 25.0% | 25.5% | 25.3% | 32.0% | 26.6% | |
| Ebit Margin | 25.3% | 26.4% | 25.3% | 25.8% | 27.0% | |
| Ebitda Margin | 27.0% | 28.1% | 27.0% | 27.1% | 28.4% | |
| Operating Profit Margin | 20.6% | 21.4% | 20.7% | 27.4% | 23.4% | |
| Pretax Profit Margin | 25.3% | 26.4% | 25.3% | 25.8% | 27.0% | |
| Continuous Operations Profit Margin | 18.2% | 19.5% | 18.7% | 19.9% | 21.7% | |
| Net Profit Margin | 18.2% | 19.5% | 18.7% | 19.9% | 21.7% | |
| Bottom Line Profit Margin | 18.2% | 19.5% | 18.7% | 19.9% | 21.7% | |
| Current Ratio | 2.402 | 2.739 | 2.344 | 2.196 | 2.960 | |
| Quick Ratio | 2.402 | 2.739 | 2.344 | 2.196 | 2.960 | |
| Solvency Ratio | 0.278 | 0.333 | 0.376 | 0.411 | 0.404 | |
| Cash Ratio | 1.247 | 1.587 | 1.156 | 1.015 | 1.946 | |
| Price To Earnings Ratio | 33.726 | 41.742 | 44.918 | 50.045 | 60.797 | |
| Price To Earnings Growth Ratio | -14.367 | 4.813 | -44.469 | 16.015 | 2.825 | |
| Forward Price To Earnings Growth Ratio | -14.367 | 4.813 | -44.469 | 16.015 | 2.825 | |
| Price To Earnings Diluted Ratio | 33.889 | 42.137 | 45.381 | 50.556 | 61.437 | |
| Price To Earnings Diluted Growth Ratio | -17.876 | 4.809 | -44.474 | 16.009 | 2.721 | |
| Price To Book Ratio | 9.148 | 10.796 | 12.647 | 15.980 | 14.725 | |
| Price To Sales Ratio | 6.135 | 8.139 | 8.390 | 9.986 | 13.171 | |
| Price To Free Cash Flow Ratio | 29.188 | 33.037 | 40.573 | 62.688 | 52.158 | |
| Price To Operating Cash Flow Ratio | 27.108 | 31.451 | 35.362 | 54.640 | 49.300 | |
| Debt To Assets Ratio | 0.102 | 0.105 | 0.044 | 0.032 | 0.022 | |
| Debt To Equity Ratio | 0.212 | 0.194 | 0.079 | 0.058 | 0.036 | |
| Debt To Capital Ratio | 0.175 | 0.162 | 0.074 | 0.055 | 0.035 | |
| Long Term Debt To Capital Ratio | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Financial Leverage Ratio | 2.072 | 1.846 | 1.816 | 1.829 | 1.639 | |
| Working Capital Turnover Ratio | 2.183 | 2.228 | 2.633 | 2.095 | 1.698 | |
| Operating Cash Flow Ratio | 0.740 | 0.886 | 0.787 | 0.590 | 0.814 | |
| Operating Cash Flow Sales Ratio | 0.226 | 0.259 | 0.237 | 0.183 | 0.267 | |
| Free Cash Flow Operating Cash Flow Ratio | 0.929 | 0.952 | 0.872 | 0.872 | 0.945 | |
| Debt Service Coverage Ratio | 16.849 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Interest Coverage Ratio | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Short Term Operating Cash Flow Coverage Ratio | 19.119 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Operating Cash Flow Coverage Ratio | 1.590 | 1.774 | 4.506 | 5.043 | 8.321 | |
| Capital Expenditure Coverage Ratio | 14.029 | 20.830 | 7.786 | 7.789 | 18.249 | |
| Dividend Paid And Capex Coverage Ratio | 1.857 | 2.218 | 1.809 | 1.531 | 2.490 | |
| Dividend Payout Ratio | 0.581 | 0.534 | 0.539 | 0.481 | 0.427 | |
| Enterprise Value Multiple | 21.806 | 27.814 | 30.001 | 35.767 | 44.274 |
Sparkline shows each ratio oldest → newest (left → right).
How the latest year compares
For each ratio: its most recent value, the change versus one year earlier, and versus its 5-year average. ▲ higher ▼ lower
| Metric | Current | vs 1Y ago | vs 5Y avg |
|---|---|---|---|
| Gross Profit Margin | 25.0% | ▼-0.5% | ▼-1.9% |
| Ebit Margin | 25.3% | ▼-1.1% | ▼-0.6% |
| Ebitda Margin | 27.0% | ▼-1.1% | ▼-0.5% |
| Operating Profit Margin | 20.6% | ▼-0.8% | ▼-2.1% |
| Pretax Profit Margin | 25.3% | ▼-1.1% | ▼-0.6% |
| Continuous Operations Profit Margin | 18.2% | ▼-1.3% | ▼-1.4% |
| Net Profit Margin | 18.2% | ▼-1.3% | ▼-1.4% |
| Bottom Line Profit Margin | 18.2% | ▼-1.3% | ▼-1.4% |
| Current Ratio | 2.402 | ▼-0.336 | ▼-0.126 |
| Quick Ratio | 2.402 | ▼-0.336 | ▼-0.126 |
| Solvency Ratio | 0.278 | ▼-0.056 | ▼-0.083 |
| Cash Ratio | 1.247 | ▼-0.340 | ▼-0.143 |
| Price To Earnings Ratio | 33.726 | ▼-8.016 | ▼-12.520 |
| Price To Earnings Growth Ratio | -14.367 | ▼-19.180 | ▼-7.330 |
| Forward Price To Earnings Growth Ratio | -14.367 | ▼-19.180 | ▼-7.330 |
| Price To Earnings Diluted Ratio | 33.889 | ▼-8.249 | ▼-12.791 |
| Price To Earnings Diluted Growth Ratio | -17.876 | ▼-22.685 | ▼-10.114 |
| Price To Book Ratio | 9.148 | ▼-1.648 | ▼-3.511 |
| Price To Sales Ratio | 6.135 | ▼-2.004 | ▼-3.029 |
| Price To Free Cash Flow Ratio | 29.189 | ▼-3.849 | ▼-14.341 |
| Price To Operating Cash Flow Ratio | 27.108 | ▼-4.343 | ▼-12.464 |
| Debt To Assets Ratio | 0.102 | ▼-0.002 | ▲0.042 |
| Debt To Equity Ratio | 0.212 | ▲0.019 | ▲0.096 |
| Debt To Capital Ratio | 0.175 | ▲0.013 | ▲0.075 |
| Long Term Debt To Capital Ratio | 0.000 | 0.000 | 0.000 |
| Financial Leverage Ratio | 2.072 | ▲0.226 | ▲0.231 |
| Working Capital Turnover Ratio | 2.183 | ▼-0.045 | ▲0.015 |
| Operating Cash Flow Ratio | 0.740 | ▼-0.146 | ▼-0.023 |
| Operating Cash Flow Sales Ratio | 0.226 | ▼-0.033 | ▼-0.008 |
| Free Cash Flow Operating Cash Flow Ratio | 0.929 | ▼-0.023 | ▲0.015 |
| Debt Service Coverage Ratio | 16.849 | ▲16.849 | ▲13.479 |
| Interest Coverage Ratio | 0.000 | 0.000 | 0.000 |
| Short Term Operating Cash Flow Coverage Ratio | 19.119 | ▲19.119 | ▲15.295 |
| Operating Cash Flow Coverage Ratio | 1.590 | ▼-0.184 | ▼-2.657 |
| Capital Expenditure Coverage Ratio | 14.029 | ▼-6.801 | ▲0.292 |
| Dividend Paid And Capex Coverage Ratio | 1.857 | ▼-0.361 | ▼-0.124 |
| Dividend Payout Ratio | 0.581 | ▲0.046 | ▲0.068 |
| Enterprise Value Multiple | 21.806 | ▼-6.008 | ▼-10.126 |
Key metrics
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Market cap | $3.57B | $4.55B | $4.50B | $5.13B | $6.14B | |
| Enterprise value | $3.43B | $4.37B | $4.34B | $4.98B | $5.86B | |
| EV / Sales | 5.90x | 7.82x | 8.09x | 9.71x | 12.56x | |
| EV / Op. cash flow | 26.05x | 30.22x | 34.11x | 53.12x | 47.03x | |
| EV / Free cash flow | 28.05x | 31.75x | 39.14x | 60.94x | 49.76x | |
| EV / EBITDA | 21.81x | 27.81x | 30.00x | 35.77x | 44.27x | |
| Net debt / EBITDA | -0.88x | -1.13x | -1.10x | -1.02x | -2.14x | |
| Current ratio | 2.40x | 2.74x | 2.34x | 2.20x | 2.96x | |
| Income quality | 1.24x | 1.33x | 1.27x | 0.92x | 1.23x | |
| Graham number | $19 | $20 | $18 | $17 | $19 | |
| Graham net-net | -$1 | $0 | $0 | $0 | $3 | |
| Tax burden | 72.0% | 74.0% | 73.8% | 77.4% | 80.4% | |
| Interest burden | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| Working capital | $249.6M | $283.7M | $217.6M | $190.1M | $299.8M | |
| Invested capital | $403.5M | $440.6M | $326.1M | $282.3M | $382.7M | |
| Return on assets | 13.1% | 14.0% | 15.5% | 17.4% | 14.8% | |
| Operating ROA | 15.1% | 16.8% | 18.1% | 22.2% | 17.1% | |
| Return on tangible assets | 13.3% | 14.2% | 15.7% | 17.7% | 15.0% | |
| Return on equity | 27.2% | 25.9% | 28.2% | 31.9% | 24.3% | |
| Return on invested capital | 13.5% | 14.3% | 16.7% | 25.2% | 16.3% | |
| Return on capital employed | 19.0% | 19.5% | 23.0% | 32.9% | 20.5% | |
| Earnings yield | 3.0% | 2.4% | 2.2% | 2.0% | 1.6% | |
| Free cash flow yield | 3.4% | 3.0% | 2.5% | 1.6% | 1.9% | |
| Capex / Op. cash flow | 7.1% | 4.8% | 12.8% | 12.8% | 5.5% | |
| Capex / Depreciation | 93.1% | 71.6% | 183.4% | 170.1% | 105.2% | |
| Capex / Sales | 1.6% | 1.2% | 3.0% | 2.3% | 1.5% | |
| SG&A / Sales | 4.4% | 4.1% | 4.6% | 56.1% | 62.9% | |
| R&D / Sales | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | |
| Stock comp / Sales | 4.1% | 4.2% | 3.8% | 4.0% | 4.1% | |
| Intangibles / Total assets | 1.1% | 1.1% | 1.3% | 1.5% | 1.3% | |
| Days sales outstanding | 114d | 105d | 114d | 121d | 109d | |
| Days payables outstanding | 6d | 5d | 4d | 9d | 3d | |
| Operating cycle | 114d | 105d | 114d | 121d | 109d | |
| Cash conversion cycle | 108d | 101d | 110d | 112d | 106d |
Change by theme
Grouped by what each metric measures. Each figure is the change over the period shown — ▲ up ▼ down versus then.
Change over 1 year
Change over 5 years
Employee count
Peer market caps
Recent news
- 2026-08-20 Are Business Services Stocks Lagging Exponent (EXPO) This Year? Here is how Exponent (EXPO) and Gen Digital (GEN) have performed compared to their sector so far this year.
- 2026-08-19 New EXPO® XL Marker Creates Bigger, Bolder Writing for Better Classroom Visibility From the Front Row to the Back Newest addition to EXPO''s portfolio features 2x larger tip* to help ideas stand out Key Summary: Designed for educators: EXPO XL helps teachers create bigger, bolder, more visible classroom content that can be read more easily from across the room. Built for maximum visibility: A double-width tip creates 2x larger lines than the best-selling EXPO Chisel marker, paired with EXPO''s most vibrant ink formula.
- 2026-08-03 Wall Street Analysts Predict a 25.65% Upside in Exponent (EXPO): Here''s What You Should Know The average of price targets set by Wall Street analysts indicates a potential upside of 25.7% in Exponent (EXPO). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
- 2026-07-30 Exponent, Inc. (EXPO) Q2 2026 Earnings Call Transcript Exponent, Inc. (EXPO) Q2 2026 Earnings Call Transcript
- 2026-07-30 Exponent Q2 Earnings Call Highlights Exponent NASDAQ: EXPO reported double-digit revenue and earnings growth for the second quarter of 2026, supported by demand for user research involving artificial intelligence-enabled products, utility-sector risk management work, and dispute-related consulting across consumer products, chemicals and transportation.
- 2026-07-30 Exponent (EXPO) Surpasses Q2 Earnings and Revenue Estimates Exponent (EXPO) came out with quarterly earnings of $0.6 per share, beating the Zacks Consensus Estimate of $0.55 per share. This compares to earnings of $0.52 per share a year ago.
- 2026-07-30 Exponent Declares Regular Quarterly Dividend for Q3 2026 and Increases Stock Repurchase Authorization by $50 Million MENLO PARK, Calif., July 30, 2026 (GLOBE NEWSWIRE) -- Exponent, Inc. (Nasdaq: EXPO) today announced that its Board of Directors has declared a quarterly cash dividend of $0.31 per share of common stock to be paid on September 18, 2026, to all common stockholders of record as of September 4, 2026.
- 2026-07-30 Exponent Reports Second Quarter 2026 Financial Results MENLO PARK, Calif., July 30, 2026 (GLOBE NEWSWIRE) -- Exponent, Inc. (Nasdaq: EXPO) today reported financial results for the second quarter of fiscal year 2026 ended July 3, 2026.
- 2026-07-09 Exponent to Announce Second Quarter of Fiscal Year 2026 Results and Host Quarterly Conference Call on July 30, 2026 MENLO PARK, Calif., July 09, 2026 (GLOBE NEWSWIRE) -- Exponent, Inc. (Nasdaq: EXPO), today announced that it will report Second Quarter of fiscal year 2026 financial results for the period ended July 3, 2026 following the close of the market on Thursday, July 30, 2026. On that day, Chief Executive Officer Dr. Catherine Corrigan, President John Pye, Executive Vice President Richard Schlenker, and Chief Financial Officer Eric Anderson, will host a conference call and webcast at 4:30 p.m. ET (1:30 p.m. PT) to discuss the Company''s business and financial results.
- 2026-07-07 Exponent: AI Makes The Work More Complex, Not Less Valuable Exponent Inc. receives a buy rating, driven by its expert consulting model in high-stakes, complex technical domains. EXPO''s value proposition lies in its deep technical talent, critical for problems where failure is costly and regulatory scrutiny is high. The AI debate is a catalyst: rising complexity in physical systems should increase demand for EXPO''s services, not diminish it.